EP Patent

EP1534367A1 — Medicament dispenser

Assigned to Glaxo Group Ltd · Expires 2005-06-01 · 21y expired

What this patent protects

There is provided a medicament dispenser device (100) for use in the delivery of a combination medicament product. The device comprises a first medicament container (101a) for containing a first medicament component; first release means (106a) for releasing the contents of said f…

USPTO Abstract

There is provided a medicament dispenser device (100) for use in the delivery of a combination medicament product. The device comprises a first medicament container (101a) for containing a first medicament component; first release means (106a) for releasing the contents of said first medicament container (101a); at least one further medicament container (101b) for containing at least one further medicament component; at least one further release means (106b) for releasing the contents of each said at least one further medicament container (101b); and mixing means (140) for promoting the mixing of the released contents of the first and at least one further medicament container (101a, b). The first medicament component is kept separate from the at least one further medicament component until the point of release thereof for delivery in combination.

Drugs covered by this patent

Patent Metadata

Patent number
EP1534367A1
Jurisdiction
EP
Classification
—
Expires
2005-06-01
Drug substance claim
No
Drug product claim
No
Assignee
Glaxo Group Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.